Showing 20 of 203 recruiting trials for “combined-hepatocellular-carcinoma-and-cholangiocarcinoma”
Immunotherapy and Radioembolisation for Metastatic Hepatocellular Carcinoma
[68Ga]Ga-FAPI-46 Positron Emission Tomography (PET) Scan to Improve the Imaging of Pancreatic and Bile Duct Cancer
👨⚕️ Rutger-Jan Swijnenburg, MD, PhD, Amsterdam UMC, location AMC📍 1 site📅 Started Feb 2023View details ↗
Proton Beam Radiotherapy Followed by Tecentriq and Avastin for Primary Liver Cancer With Vp2-4 Portal Vein Invasion
A Phase III Study of AK104 as Adjuvant Therapy in HCC With High Risk of Recurrence After Curative Resection
RecruitingNCT06806579 ↗
Atezolizumab-bevacizumab and Other Immunotherapies: Real-life Experience for Treatment of Hepatocellular Carcinoma
👨⚕️ Francesco Tovoli, MD, IRCCS Azienda Ospedaliero-Universitaria di Bologna📍 24 sites📅 Started Dec 2022View details ↗
Ori-C101Chimeric Antigen Receptor (CAR) Modified T Cells for the Treatment of HCC
A Study of ICP-192 in Patients With FGFR2-Rearranged Unresectable or Metastatic Intrahepatic Cholangiocarcinoma
the Efficacy and Safety of Rulonilimab in Combination With Lenvatinib in Hepatocellular Carcinoma
👨⚕️ Cai Jian qiang, Cancer Institute and Hospital, Chinese Academy of Medical Sciences📍 5 sites📅 Started Nov 2022View details ↗
Lenvatinib Plus I-125 Seed Brachytherapy vs. Lenvatinib for TACE-refractory HCC
🏥 Second Affiliated Hospital of Guangzhou Medical University📍 1 site📅 Started Nov 2022View details ↗
A Study of the Application of HAIC in Advanced HCC Previously Treated With ICIs and Antiangiogenic Agents
Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases
TARGETed Therapy Drug MONITOring in DIGestive Oncology
Atezolizumab+Bevacizumab+SBRT in Unresectable HCC
Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC
👨⚕️ Wenxiong Xu, Doctor, Third Affiliated Hospital, Sun Yat-Sen University📍 1 site📅 Started Aug 2022View details ↗
Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma
Neoadjuvant Combination Therapy of Lenvatinib and TACE for Transplant-Eligible Large Hepatocellular Carcinoma Patients
👨⚕️ Maen Abdelrahim, MD, The Methodist Hospital Research Institute📍 1 site📅 Started Jun 2022View details ↗
RecruitingNCT05534906 ↗
The Detection of Small Early Liver Cancer With Natural History Follow up
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Liver Cancer Disparities in American Indian and Alaska Native Persons
A National Phase II Study of Proton Therapy in Hepatocellular Carcinoma
👨⚕️ Britta Weber, MD PhD, Danish Center of Particle Therapy📍 3 sites📅 Started Apr 2022View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →